SBC Medical's Q4 earnings exceeded expectations

Irvine, California - On Friday, SBC Medical Group Holdings Incorporated (NASDAQ: SBC) reported fourth-quarter results that exceeded earnings expectations, but revenue fell short of analyst estimates.

After the announcement, the company’s stock rose 0.26% in pre-market trading.

The healthcare service provider reported an adjusted earnings per share of $0.14 for the fourth quarter ending December 31, 2025, which is $0.03 higher than the consensus estimate of $0.11.

Earnings per share for the quarter grew 133% compared to $0.06 in the same period last year. However, revenue of $39.57 million missed the expected $44.02 million, representing an 11% decline from $44.42 million in the same period last year.

Net income attributable to SBC Medical soared 117% year-over-year to $14 million, with net profit margin expanding from 15% in the same period last year to 36%.

Despite the revenue decline, the company’s profitability improved, which management attributed to a business restructuring conducted in 2024 and adjustments to franchise fee arrangements implemented in April 2025.

Chairman and CEO Yoshiyuki Aikawa stated, “Our full-year performance for 2025 reflects that the company is in a transformation phase. Revenue decreased 15% to $174 million, primarily due to two structural changes: the business restructuring in 2024 and the adjustments to franchise fee arrangements implemented in April 2025.”

For the full year 2025, SBC Medical reported adjusted earnings per share of $0.50, a 4% year-over-year increase, with revenue of $173.61 million, down 15% from $205.42 million in 2024. As of December 31, 2025, the company expanded its franchise network to 283 locations, an increase of 34 from the previous year, serving 6.6 million customers, a 12% year-over-year growth.

This article was translated with the assistance of artificial intelligence. For more information, please see our terms of use.